A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties (Q39177528)
Jump to navigation
Jump to search
scientific article published on 18 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties |
scientific article published on 18 March 2013 |
Statements
1 reference
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties (English)
1 reference
1 reference
Vikas K Bhat
1 reference
Barry D Kerr
1 reference
18 March 2013
1 reference
1 reference
85
1 reference
11
1 reference
1655-1662
1 reference
Identifiers
1 reference
1 reference